RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,000 | +22.0% | 3,000 | 0.0% | 0.00% | – |
| Q2 2023 | $7,380 | +8.8% | 3,000 | 0.0% | 0.00% | – |
| Q1 2023 | $6,780 | -35.2% | 3,000 | 0.0% | 0.00% | – |
| Q4 2022 | $10,470 | -90.6% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $111,000 | +94.7% | 3,000 | 0.0% | 0.00% | – |
| Q2 2022 | $57,000 | -29.6% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $81,000 | -40.0% | 3,000 | -50.0% | 0.00% | 0.0% |
| Q4 2021 | $135,000 | -14.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $157,000 | -18.2% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $192,000 | -9.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $211,000 | +9.9% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $192,000 | -15.0% | 6,000 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $226,000 | -16.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $269,000 | +31.2% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $205,000 | -12.4% | 6,000 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $234,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |